Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

NCT07046663

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy

SC Dermatologia, ASST-Papa Giovanni XXIII, Bergamo, Italy

UO Dermatologia - IRCCS Policlinico S.Orsola-Malpighi Bologna, Italy

UO Dermatologia ASST Spedali Civili Brescia Brescia, Italy

View all 20 locations

View Trial Details

Not yet recruiting

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

NCT07034755

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Blood Protein Disorders, Cardiovascular Diseases, +15 more
Locations: The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not yet recruiting

Online Physical Activity and Health Counseling for Survivors of Childhood Acute Lymphoblastic Leukemia

NCT07042932

Conditions: Acute Lymphoblastic Leukemia ALL, Behavior, Childhood Cancer Survivors, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

NCT07043218

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Shanghai Tongji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

NCT06720207

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

NCT07032532

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Not yet recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )

NCT07032324

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL

NCT07031700

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Effect of Non-pharmacological Methods on Pain, Fear

NCT07032181

Conditions: Children, Fear, Hematologic Diseases, +15 more
Locations: Koc University Istanbul, Zeytinburnu, Turkey (Türkiye)

View Trial Details

Not yet recruiting

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

NCT07024147

Conditions: B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations: Beijing cancer hospital Beijing, Beijing Municipality, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions